Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.

BACKGROUND The Apolipoprotein E4 (ApoE4) genotype is strongly associated with Alzheimer's disease (AD), although the presence of the ApoE4 allele alone is not sufficient to explain AD. The pathophysiology of amnestic mild cognitive impairment (aMCI) remains unclear. OBJECTIVE This study aims to examine associations between peripheral blood biomarkers coupled with ApoE4 and episodic and semantic memory. METHODS The CERAD battery was completed and various biomarkers were assayed in 60 subjects with aMCI, 60 with AD, and 62 healthy controls. RESULTS Deficits in semantic and episodic memory were significantly predicted by anion gap and bicarbonate, albumin, and glucose coupled with ApoE4. Furthermore, these peripheral biomarkers interacted with ApoE to predict greater memory impairments. CONCLUSIONS Peripheral blood biomarkers may interact with pathways related to ApoE4 to predict greater semantic and episodic memory impairments, thus contributing to the pathophysiology of aMCI and AD. Our data suggest that the transition from aMCI to AD could at least in some cases be associated with significant interactions between ApoE4 and those peripheral blood biomarkers.

[1]  M. Maes,et al.  Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer’s dementia and mild cognitive impairment: clinical and biomarker correlates. , 2018, Aging & mental health.

[2]  M. Maes,et al.  Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients , 2018, Neurotoxicity Research.

[3]  J. Brandon,et al.  APOE and Alzheimer’s Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction , 2018, Front. Aging Neurosci..

[4]  M. Maes,et al.  Could Alzheimer’s Disease Originate in the Periphery and If So How So? , 2018, Molecular Neurobiology.

[5]  Jackson T. Wright,et al.  Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[6]  M. McAdams‐DeMarco,et al.  The Role of Bicarbonate in Cognition: Acidosis May Be Corrosive to the Brain. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[7]  M. Maes,et al.  Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer’s Disease Tests: A Multivariate and Machine Learning Study , 2018, Dementia and Geriatric Cognitive Disorders.

[8]  M. Maes,et al.  Bright light and oxygen therapies decrease delirium risk in critically ill surgical patients by targeting sleep and acid-base disturbances , 2018, Psychiatry Research.

[9]  M. Maes,et al.  In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer’s Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits , 2018, Molecular Neurobiology.

[10]  H. P. Priyanka,et al.  Interrelationship between Mini‐Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease , 2017, Geriatrics & gerontology international.

[11]  A. Simmons,et al.  Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid , 2017, NeuroImage: Clinical.

[12]  A. Carvalho,et al.  Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[13]  J. Little,et al.  High Glucose Enhances Neurotoxicity and Inflammatory Cytokine Secretion by Stimulated Human Astrocytes. , 2017, Current Alzheimer research.

[14]  A. Sharrett,et al.  Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline , 2017, Diabetes Care.

[15]  Toshitaka Nagao,et al.  Plaque formation and the intraneuronal accumulation of β‐amyloid in Alzheimer's disease , 2017, Pathology international.

[16]  Y. Fujiwara,et al.  Albumin, Hemoglobin, and the Trajectory of Cognitive Function in Community-Dwelling Older Japanese: A 13-Year Longitudinal Study. , 2017, The journal of prevention of Alzheimer's disease.

[17]  C. Gonçalves,et al.  Fluctuations in glucose levels induce glial toxicity with glutamatergic, oxidative and inflammatory implications. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[18]  A. Pérez Romero,et al.  The importance of behavioural and pyschological symptoms in Alzheimer's disease. , 2018, Neurologia.

[19]  M. Dhenain,et al.  Impaired fasting blood glucose is associated to cognitive impairment and cerebral atrophy in middle-aged non-human primates , 2016, Aging.

[20]  F. Infurna,et al.  Glycated haemoglobin (HbA1c), diabetes and trajectories of change in episodic memory performance , 2016, Journal of Epidemiology & Community Health.

[21]  Weili Xu,et al.  Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial , 2016, Mediators of inflammation.

[22]  A. Pérez Romero,et al.  The importance of behavioural and pyschological symptoms in Alzheimer's disease. , 2016, Neurologia.

[23]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[24]  T. Montine,et al.  Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. , 2015, JAMA neurology.

[25]  F. Martel,et al.  Folates and aging: Role in mild cognitive impairment, dementia and depression , 2015, Ageing Research Reviews.

[26]  D. Cuadras,et al.  Serum albumin and health in older people: Review and meta analysis. , 2015, Maturitas.

[27]  B. Afşar,et al.  Association between serum bicarbonate and pH with depression, cognition and sleep quality in hemodialysis patients , 2015, Renal failure.

[28]  P. Wolf,et al.  APOE and mild cognitive impairment: the Framingham Heart Study. , 2015, Age and ageing.

[29]  R. Kessels,et al.  Effects of glucose load on cognitive functions in elderly people. , 2015, Nutrition reviews.

[30]  Seong Yoon Kim,et al.  Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment , 2014, Nutrition Journal.

[31]  Y. Liu,et al.  Towards bridging the gap between acid-base transporters and neuronal excitability modulation. , 2014, International journal of physiology, pathophysiology and pharmacology.

[32]  M. Barbagallo,et al.  Type 2 diabetes mellitus and Alzheimer's disease. , 2014, World journal of diabetes.

[33]  Toshio Tanaka,et al.  IL-6 in inflammation, immunity, and disease. , 2014, Cold Spring Harbor perspectives in biology.

[34]  B. Vissel,et al.  Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease , 2014, Acta neuropathologica communications.

[35]  L. Nyberg,et al.  Serum Metabolomic Biomarkers of Dementia , 2014, Dementia and Geriatric Cognitive Disorders Extra.

[36]  Alina Jurcoane,et al.  Differential effects of the ApoE4 genotype on brain structure and function , 2014, NeuroImage.

[37]  L. Fratiglioni,et al.  Mild cognitive impairment: a concept in evolution , 2014, Journal of internal medicine.

[38]  Guojun Bu,et al.  ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners? , 2014, Neuron.

[39]  Soyeon Ahn,et al.  Serum anion gap is predictive of mortality in an elderly population , 2014, Experimental Gerontology.

[40]  Holger Jahn,et al.  Memory loss in Alzheimer's disease , 2013, Dialogues in clinical neuroscience.

[41]  Andreas Meisel,et al.  Sugar for the brain: the role of glucose in physiological and pathological brain function , 2013, Trends in Neurosciences.

[42]  S. Haneuse,et al.  Glucose levels and risk of dementia. , 2013, The New England journal of medicine.

[43]  A. Sinning,et al.  Minireview: pH and synaptic transmission , 2013, FEBS letters.

[44]  R. Sidman,et al.  Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis , 2013, Proceedings of the National Academy of Sciences.

[45]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[46]  D. Bennett,et al.  Apolipoprotein E and Change in Episodic Memory in Blacks and Whites , 2013, Neuroepidemiology.

[47]  M. Daly,et al.  Variant TREM2 as risk factor for Alzheimer's disease. , 2013, The New England journal of medicine.

[48]  D. Holtzman,et al.  The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. , 2012, Cold Spring Harbor perspectives in medicine.

[49]  E. Mukaetova-Ladinska,et al.  Behavioral and Psychological Symptoms of Dementia , 2012, Front. Neur..

[50]  W. M. van der Flier,et al.  Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[51]  Anand Viswanathan,et al.  Cerebral amyloid angiopathy in the elderly , 2011, Annals of neurology.

[52]  Magda Tsolaki,et al.  Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. , 2011, Journal of Alzheimer's disease : JAD.

[53]  Lippincott Williams Wilkins,et al.  Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination , 2011, Neurology.

[54]  S. Hahn,et al.  Memory Impairment and Executive Dysfunction are Associated with Inadequately Controlled Diabetes in Older Adults , 2011, Journal of primary care & community health.

[55]  C. DeCarli,et al.  Vitamin B12, cognition, and brain MRI measures , 2011, Neurology.

[56]  V. Perry,et al.  Proinflammatory cytokines, sickness behavior, and Alzheimer disease , 2011, Neurology.

[57]  J. Neugroschl,et al.  Alzheimer's disease: diagnosis and treatment across the spectrum of disease severity. , 2011, The Mount Sinai journal of medicine, New York.

[58]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[59]  C. Rowe,et al.  Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. , 2011, Journal of Alzheimer's disease : JAD.

[60]  V. Sapira,et al.  Study of interleukin-6 production in Alzheimer's disease. , 2011, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[61]  S. Sünram-Lea,et al.  The Effects of Glucose Dose and Dual Task Performance on Memory for Emotional Material Introduction , 2022 .

[62]  D. Bennett,et al.  The APOE ε4 Allele Is Associated with Incident Mild Cognitive Impairment among Community-Dwelling Older Persons , 2009, Neuroepidemiology.

[63]  V. Perry,et al.  Systemic inflammation and disease progression in Alzheimer disease , 2009, Neurology.

[64]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[65]  J. Smallwood,et al.  The effects of glucose ingestion and glucose regulation on memory performance in older adults with mild cognitive impairment , 2009, European Journal of Clinical Nutrition.

[66]  Steve Iliffe,et al.  Alzheimer’s disease , 2009, BMJ : British Medical Journal.

[67]  Z. Khachaturian.  Alzheimer's & Dementia: The Journal of the Alzheimer's Association , 2008, Alzheimer's & Dementia.

[68]  Gerald van Belle,et al.  Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years , 2008, Alzheimer's & Dementia.

[69]  N. Gardiner,et al.  Glucose neurotoxicity , 2008, Nature Reviews Neuroscience.

[70]  G. Ko,et al.  Effects of age on plasma glucose levels in non-diabetic Hong Kong Chinese. , 2006, Croatian medical journal.

[71]  A. Nobre,et al.  The effects of combined caffeine and glucose drinks on attention in the human brain , 2005, Nutritional neuroscience.

[72]  Lars Bäckman,et al.  Apolipoprotein E and cognitive performance: a meta-analysis. , 2004, Psychology and aging.

[73]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[74]  David A. Bennett,et al.  The apolipoprotein E ε2 allele and decline in episodic memory , 2002 .

[75]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[76]  D. Butterfield,et al.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress , 2002 .

[77]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[78]  E. Bosmans,et al.  Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease. , 1999, Journal of psychiatric research.

[79]  L. Bailey,et al.  Folate metabolism and requirements. , 1999, The Journal of nutrition.

[80]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[81]  L. Thal,et al.  Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease , 1996, Neurology.

[82]  W. Klein,et al.  Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. , 1996, The Journal of biological chemistry.

[83]  A D Roses,et al.  Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.

[84]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[85]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[86]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[87]  A. Spindler,et al.  Nutritional Status and Psychometric Test Scores in Cognitively Impaired Elders a , 1989, Annals of the New York Academy of Sciences.